An investigation into the metabolic and cardiovascular effects of phytocannabinoids using in vivo and in vitro techniques
Metabolic syndrome, first described as Syndrome X, includes a cluster of metabolic abnormalities including visceral obesity, insulin resistance, dyslipidaemia and hypertension. The pathophysiology of metabolic syndrome is complex, however, visceral adiposity and insulin resistance are thought to pla...
| Main Author: | |
|---|---|
| Published: |
University of Nottingham
2016
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701229 |